[Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].

In a double-blind controlled trial, we have compared the therapeutic effectiveness of Diflorason-Diacetate and Clobetasol-17-propionate with 50 PUVA-resistent psoriatics. Both externals resulted in a highly significant decline of psoriatic symptoms. The difference in therapeutic achievement between the two respective groups was statistically not significant. According to the physician's overall judgement, however, Clobetasol was favored significantly over Diflorasone-Diacetate, while the patients only showed a slight preference for Clobetasol. Based on these findings and previously published results, Diflorasone-Diacetate may be classified as one of the most effective skin corticosteroids, ranging just behind Clobetasol.
AuthorsT A Rozman, K D Wiedey, H D Renovanz
JournalZeitschrift für Hautkrankheiten (Z Hautkr) Vol. 58 Issue 6 Pg. 398-409 (Mar 15 1983) ISSN: 0301-0481 [Print] GERMANY, WEST
Vernacular TitleVergleichsstudie mit Diflorasondiacetat und Clobetasol-17-Propionat bei PUVA-resistenter Psoriasis.
PMID6342288 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article)
Chemical References
  • Betamethasone
  • Clobetasol
  • diflorasone
  • Betamethasone (analogs & derivatives, therapeutic use)
  • Clinical Trials as Topic
  • Clobetasol (analogs & derivatives, therapeutic use)
  • Double-Blind Method
  • Humans
  • PUVA Therapy
  • Photochemotherapy
  • Psoriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: